5-Lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection

Microbes and Infection

Volumn 12, Issue 8-9, 2010, Pages 587-597

  Pavanelli, Wander R ^a   Gutierrez, Fredy R S ^a   Mariano, Flávia S ^a   Prado, Cibele M ^a   Ferreira, Beatriz Rossetti ^a   Teixeira, Mauro Martins ^b   Canetti, Cláudio ^c   Rossi, Marcos A ^a   Cunha, Fernando Q ^a   Silva, João S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

5 Lipoxygenase; Inflammation; Leukotrienes; Myocarditis; Trypanosoma cruzi

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; GAMMA INTERFERON; LEUKOTRIENE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4 CD8 RATIO; CELL INFILTRATION; CHAGAS DISEASE; ENZYME SYNTHESIS; FEMALE; HEART; MORTALITY; MOUSE; MYOCARDITIS; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; SURVIVAL RATE; TRYPANOSOMA CRUZI; ANIMAL; DEFICIENCY; DISEASE MODEL; HEART MUSCLE; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; SURVIVAL;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CHAGAS CARDIOMYOPATHY; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOTRIENES; MICE; MICE, KNOCKOUT; MYOCARDIUM; PARASITEMIA; SURVIVAL ANALYSIS; TRYPANOSOMA CRUZI;

ANIMALIA; MUS; TRYPANOSOMA CRUZI;

EID: 77954953953     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.03.016     Document Type: Article

References (51)

1. Koberle F. Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv. Parasitol. 1968, 6:63-116.
2. Rossi M.A. Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease. Am. Heart J. 1990, 120(1):233-236.
3. Teixeira M.M., Gazzinelli R.T., Silva J.S. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol. 2002, 18(6):262-265.
4. Gorelik G., Borda E., Postan M., Gonzalez Cappa S., Sterin-Borda L. T lymphocytes from T. cruzi-infected mice alter heart contractility: participation of arachidonic acid metabolites. J. Mol. Cell. Cardiol. 1992, 24(1):9-20.
5. Chen X.S., Sheller J.R., Johnson E.N., Funk C.D. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 1994, 372(6502):179-182.
6. Dixon R.A., Diehl R.E., Opas E., Rands E., Vickers P.J., Evans J.F., Gillard J.W., Miller D.K. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 1990, 343(6255):282-284.
7. Aliberti J.C., Souto J.T., Marino A.P., Lannes-Vieira J., Teixeira M.M., Farber J., Gazzinelli R.T., Silva J.S. Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am. J. Pathol. 2001, 158(4):1433-1440.
8. Marino A.P., Silva A.A., Santos P.V., Pinto L.M., Gazinelli R.T., Teixeira M.M., Lannes-Vieira J. CC-chemokine receptors: a potential therapeutic target for Trypanosoma cruzi-elicited myocarditis. Mem. Inst. Oswaldo Cruz. 2005, 100(Suppl. 1):93-96.
9. Aliberti J.C., Machado F.S., Souto J.T., Campanelli A.P., Teixeira M.M., Gazzinelli R.T., Silva J.S. beta-Chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi. Infect. Immun. 1999, 67(9):4819-4826.
10. Leon J.S., Engman D.M. Autoimmunity in Chagas heart disease. Int. J. Parasitol. 2001, 31(5-6):555-561.
11. Kierszenbaum F. Chagas' disease and the autoimmunity hypothesis. Clin. Microbiol. Rev. 1999, 12(2):210-223.
12. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001, 294(5548):1871-1875.
13. Kumar V., Fausto N., Abbas A. Robbins and Cotran. Pathological Basis of Disease 2004, W.B. Saunders Company, Philadelphia, PA, USA.
14. Martin P., Leibovich S.J. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell. Biol. 2005, 15(11):599-607.
15. Goulet J.L., Griffiths R.C., Ruiz P., Spurney R.F., Pisetsky D.S., Koller B.H., Coffman T.M. Deficiency of 5-lipoxygenase abolishes sex-related survival differences in MRL-lpr/lpr mice. J. Immunol. 1999, 163(1):359-366.
16. Rouzer C.A., Shimizu T., Samuelsson B. On the nature of the 5-lipoxygenase reaction in human leukocytes: characterization of a membrane-associated stimulatory factor. Proc. Natl. Acad. Sci. U.S.A. 1985, 82(22):7505-7509.
17. Murakami M., Penrose J.F., Urade Y., Austen K.F., Arm J.P. Interleukin 4 suppresses c-kit ligand-induced expression of cytosolic phospholipase A2 and prostaglandin endoperoxide synthase 2 and their roles in separate pathways of eicosanoid synthesis in mouse bone marrow-derived mast cells. Proc. Natl. Acad. Sci. U.S.A. 1995, 92(13):6107-6111.
18. Henderson W.R. The role of leukotrienes in inflammation. Ann. Intern. Med. 1994, 121(9):684-697.
19. Wirth J.J., Kierszenbaum F. Stimulatory effects of leukotriene B4 on macrophage association with and intracellular destruction of Trypanosoma cruzi. J. Immunol. 1985, 134(3):1989-1993.
20. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983, 220(4597):568-575.
21. Rola-Pleszczynski M. Differential effects of leukotriene B4 on T4+ and T8+ lymphocyte phenotype and immunoregulatory functions. J. Immunol. 1985, 135(2):1357-1360.
22. Rola-Pleszczynski M., Bouvrette L., Gingras D., Girard M. Identification of interferon-gamma as the lymphokine that mediates leukotriene B4-induced immunoregulation. J. Immunol. 1987, 139(2):513-517.
23. Talvani A., Machado F.S., Santana G.C., Klein A., Barcelos L., Silva J.S., Teixeira M.M. Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. Infect. Immun. 2002, 70(8):4247-4253.
24. Michailowsky V., Silva N.M., Rocha C.D., Vieira L.Q., Lannes-Vieira J., Gazzinelli R.T. Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. Am. J. Pathol. 2001, 159(5):1723-1733.
25. Rossi M.A. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J. Hypertens. 1998, 16(7):1031-1041.
26. Camargos E.R., Franco D.J., Garcia C.M., Dutra A.P., Teixeira A.L., ChiariConcei E., Machado C.R. Infection with different Trypanosoma cruzi populations in rats: myocarditis, cardiac sympathetic denervation, and involvement of digestive organs. Am. J. Trop. Med. Hyg. 2000, 62(5):604-612.
27. Garcia S.B., Paula J.S., Giovannetti G.S., Zenha F., Ramalho E.M., Zucoloto S., Silva J.S., Cunha F.Q. Nitric oxide is involved in the lesions of the peripheral autonomic neurons observed in the acute phase of experimental Trypanosoma cruzi infection. Exp. Parasitol. 1999, 93(4):191-197.
28. Kim C.H. The greater chemotactic network for lymphocyte trafficking: chemokines and beyond. Curr. Opin. Hematol. 2005, 12(4):298-304.
29. Tager A.M., Bromley S.K., Medoff B.D., Islam S.A., Bercury S.D., Friedrich E.B., Carafone A.D., Gerszten R.E., Luster A.D. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat. Immunol. 2003, 4(10):982-990.
30. Michelin M.A., Silva J.S., Cunha F.Q. Inducible cyclooxygenase released prostaglandin mediates immunosuppression in acute phase of experimental Trypanosoma cruzi infection. Exp. Parasitol. 2005, 111(2):71-79.
31. Brener Z., Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int. Arch. Allergy. Immunol. 1997, 114(2):103-110.
32. Abrahamsohn I.A., Coffman R.L. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J. Immunol. 1995, 155(8):3955-3963.
33. Martins G.A., Cardoso M.A., Aliberti J.C., Silva J.S. Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice. Immunol. Lett. 1998, 63(2):113-120.
34. Feng Q., Lu X., Jones D.L., Shen J., Arnold J.M. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 2001, 104(6):700-704.
35. Borges C.L., Cecchini R., Tatakihara V.L., Malvezi A.D., Yamada-Ogatta S.F., Rizzo L.V., Pinge-Filho P. 5-Lipoxygenase plays a role in the control of parasite burden and contributes to oxidative damage of erythrocytes in murine Chagas' disease. Immunol. Lett. 2009, 123(1):38-45.
36. Peters S.P., Creticos P.S., Naclerio R.M., Schleimer R.P., MacGlashan D.W., Adkinson N.F., Norman P.S., Lichtenstein L.M. IgE-mediated leukotriene release in vitro and in vivo. Trans. Assoc. Am. Physicians. 1984, 97:260-267.
37. Konstan M.W., Walenga R.W., Hilliard K.A., Hilliard J.B. Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis. Am. Rev. Respir. Dis. 1993, 148(4 Pt 1):896-901.
38. Brain S.D., Camp R.D., Cunningham F.M., Dowd P.M., Greaves M.W., Black A.K. Leukotriene B4-like material in scale of psoriatic skin lesions. Br. J. Pharmacol. 1984, 83(1):313-317.
39. Ahmadzadeh N., Shingu M., Nobunaga M., Tawara T. Relationship between leukotriene B4 and immunological parameters in rheumatoid synovial fluids. Inflammation 1991, 15(6):497-503.
40. Sharon P., Stenson W.F. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 1984, 86(3):453-460.
41. Henderson W.R., Chi E.Y. The importance of leukotrienes in mast cell-mediated Toxoplasma gondii cytotoxicity. J. Infect. Dis. 1998, 177(5):1437-1443.
42. Serezani C.H., Perrela J.H., Russo M., Peters-Golden M., Jancar S. Leukotrienes are essential for the control of Leishmania amazonensis infection and contribute to strain variation in susceptibility. J. Immunol. 2006, 177(5):3201-3208.
43. Machado E.R., Ueta M.T., Lourenco E.V., Anibal F.F., Sorgi C.A., Soares E.G., Roque-Barreira M.C., Medeiros A.I., Faccioli L.H. Leukotrienes play a role in the control of parasite burden in murine strongyloidiasis. J. Immunol. 2005, 175(6):3892-3899.
44. Wirth J.J., Kierszenbaum F. Effects of leukotriene C4 on macrophage association with and intracellular fate of Trypanosoma cruzi. Mol. Biochem. Parasitol. 1985, 15(1):1-10.
45. Dahlen S.E., Bjork J., Hedqvist P., Arfors K.E., Hammarstrom S., Lindgren J.A., Samuelsson B. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc. Natl. Acad. Sci. U.S.A. 1981, 78(6):3887-3891.
46. Aliberti J., Hieny S., Reis e Sousa C., Serhan C.N., Sher A. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat. Immunol. 2002, 3(1):76-82.
47. Minoprio P., Eisen H., Joskowicz M., Pereira P., Coutinho A. Suppression of polyclonal antibody production in Trypanosoma cruzi-infected mice by treatment with anti-L3T4 antibodies. J. Immunol. 1987, 139(2):545-550.
48. Tarleton R.L., Sun J., Zhang L., Postan M. Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect. Immun. 1994, 62(5):1820-1829.
49. Piguet P.F., Collart M.A., Grau G.E., Kapanci Y., Vassalli P. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 1989, 170(3):655-663.
50. McGaha T.L., Le M., Kodera T., Stoica C., Zhu J., Paul W.E., Bona C.A. Molecular mechanisms of interleukin-4-induced up-regulation of type I collagen gene expression in murine fibroblasts. Arthritis Rheum. 2003, 48(8):2275-2284.
51. Martin D.L., Postan M., Lucas P., Gress R., Tarleton R.L. TGF-beta regulates pathology but not tissue CD8+T cell dysfunction during experimental Trypanosoma cruzi infection. Eur. J. Immunol. 2007, 37(10):2764-2771.